Part 2: Healthcare’s ‘Corona Effect’

Ten expectations regarding voluntary offerings, telemedicine, direct contracting, and more as COVID-19 unfolds.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Part 1: Effects of Unemployment

The US Department of Labor cited a record-breaking 6.6 million unemployment claims filed last week. What's next?

Partner, Health and Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Oral health can be the key driver of patients' ER bills. Proper care for the body’s “gateway” is a compelling value proposition for consumers and the healthcare ecosystem.

Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Fourteen percent of physicians offer virtual visits. But a new CMS rule may make telehealth more commonplace.

Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

When it comes to health benefits, paying more doesn't always get you more. But, consumers will open up their wallets for better value.

Partner, Health and Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

From Walmart to Amazon to 23andMe, these 11 market scenarios paint a picture of what disruption looks like, both in and out of healthcare.

Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Chief Strategy Officer, BCBS of Massachusetts
Partner, Health & Life Sciences, Oliver Wyman

Digital distribution industry leaders face a tipping point. Here's how to stay ahead of healthcare’s ongoing disruption.

Chief Product Officer and Co-Founder, Maxwell Health
Partner, Health and Life Sciences, Oliver Wyman

Tomorrow’s healthcare consumer still wants a personalized experience – like that of Apple and Netflix. Here’s how the industry can bridge that gap.

Partner, Health and Life Sciences, Oliver Wyman
Chief Client and Strategy Officer, Lippincott

In the face of today’s market turmoil and revenue insecurity, ancillary products offer a stable, growing profit pool for health plans.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

New political climate positions private exchanges for take-off. Learn why.

Partner, Health and Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe
Load More